Top Markets
Coin of the day
Eastgate Biotech Corp. Eastgate Biotech Corp.

Eastgate Biotech Corp.

ETBI
Rangering i aksjer #34128
EastGate Biotech Corp. is a pharmaceutical company specializing in the... EastGate Biotech Corp. is a pharmaceutical company specializing in the production and distribution of nutraceuticals. These products are rooted in natural therapies and designed for natural absorption within the body. The firm employs cutting-edge nanotechnologies to provide healthier options compared to conventional pharmaceuticals, which often lead to detrimental side effects and unforeseen issues for individuals seeking to achieve and maintain good health. Among its diverse product line are E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze, and Warts X. EastGate Biotech's development process involves integrating product components into various nano-sized delivery systems. These systems include oil droplets (nanoemulsions), polymeric particles (nanoparticles), and complex combinations of polymers, lipids, and surfactants (such as hybrid nanoparticles, nanocapsules, and mixed micelles). The company has operational bases in prominent cities including New York, London SF, Cockfosters BP, Los Angeles, Chicago, and Las Vegas.
Aksjekurs
$0.003
Sist synkronisert: 2026-08-13
Markedsverdi
$6.17M
Endring (1 dag)
0.00%
Endring (1 år)
-25.00%
Land
CA
Handel Eastgate Biotech Corp. (ETBI)

Kategori

P/S-forhold for Eastgate Biotech Corp. (ETBI)
P/S-forhold per 2026 TTM: 0
Ifølge Eastgate Biotech Corp. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Eastgate Biotech Corp. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter